Acute-on-chronic liver failure in chronic hepatitis B: an update

References

• Seto WK , Lai CL , Yuen MF. Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol. 2012;27:662–669.
   PubMed Web of Science ®Google Scholar
• Sarin SK , Kumar A , Almeida JA , et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int. 2009;3:269–282.
   PubMed Web of Science ®Google Scholar
• Sarin SK , Kedarisetty CK , Abbas Z , et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8:453–471.
   PubMed Web of Science ®Google Scholar
• Olson JC , Wendon JA , Kramer DJ , et al. Intensive care of the patient with cirrhosis. Hepatology. 2011;54:1864–1872.
   PubMed Web of Science ®Google Scholar
• Moreau R , Jalan R , Gines P , et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1431–1437.
   Web of Science ®Google Scholar
• Bajaj JS. Defining acute-on-chronic liver failure: will East and West ever meet? Gastroenterology. 2013;144:1337–1339.
   PubMed Web of Science ®Google Scholar
• Wang FS , Zhang Z. Liver: how can acute-on-chronic liver failure be accurately identified? Nat Rev Gastroenterol Hepatol. 2013;10:390–391.
   PubMed Web of Science ®Google Scholar
• Shi Y , Yang Y , Hu Y , et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology. 2015;62:232–242.
   PubMed Web of Science ®Google Scholar
• Li H , Chen LY , Zhang NN , et al. Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B. Sci Rep. 2016;6:25487.
   PubMed Web of Science ®Google Scholar
• Qin G , Shao JG , Zhu YC , et al. Population-representative incidence of acute-on-chronic liver failure: a prospective cross-sectional study. J Clin Gastroenterol. 2016;50:670–675.
   PubMed Web of Science ®Google Scholar
• Zheng MH , Shi KQ , Fan YC , et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol. 2011;9:351–356.
   PubMed Web of Science ®Google Scholar
• Shi Y , Zheng MH , Yang Y , et al. Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation. J Gastroenterol Hepatol. 2015;30:712–718.
   PubMed Web of Science ®Google Scholar
• Yin S , Wang SJ , Gu WY , et al. Risk of different precipitating events for progressing to acute-on-chronic liver failure in HBV-related cirrhotic patients. J Dig Dis. 2017;18:292–301.
   PubMed Web of Science ®Google Scholar
• Sola E , Fernandez J , Gines P . Acute-on-chronic liver failure: the role of precipitating illness. Semin Liver Dis. 2016;36:117–122.
   PubMed Web of Science ®Google Scholar
• Xie GJ , Zhang HY , Chen Q , et al. Changing etiologies and outcome of liver failure in Southwest China. Virol J. 2016;13:89.
   PubMed Web of Science ®Google Scholar
• Hamid SS , Atiq M , Shehzad F , et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology. 2002;36:474–478.
   PubMed Web of Science ®Google Scholar
• Choudhury AK , Sharma MK , Maiwal R , et al. The decision for liver transplant in acute on chronic liver failure (ACLF) - first week is the crucial period - analysis of the APASL ACLF Research Consortium (AARC). Prospective data of 1021 patients. J Hepatol. 2016;64:S151–S152.
   Web of Science ®Google Scholar
• Soriano V , Sherman KE , Barreiro P . Hepatitis delta and HIV infection. AIDS. 2017;31:1.
   PubMed Web of Science ®Google Scholar
• Devarbhavi H , Choudhury AK , Reddy VV , et al. Acute on chronic liver failure secondary to drugs: causes, outcome and predictors of mortality. J Hepatol 2016;64, S232.
   PubMed Web of Science ®Google Scholar
• Fausto N . Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004;39:1477–1487.
   PubMed Web of Science ®Google Scholar
• Wiemann SU , Satyanarayana A , Tsahuridu M , et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. Faseb J. 2002;16:935–942.
   PubMed Web of Science ®Google Scholar
• Albillos A , Lario M , Alvarez-Mon M . Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61:1385–1396.
   PubMed Web of Science ®Google Scholar
• Shi Y , Wu W , Yang Y , et al. Decreased Tim-3 expression is associated with functional abnormalities of monocytes in decompensated cirrhosis without overt bacterial infection. J Hepatol. 2015;63:60–67.
   PubMed Web of Science ®Google Scholar
• Tan W , Xia J , Dan Y , et al. Genome-wide association study identifies HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure. Gut. 2017 Jan 27. pii: gutjnl-2016-313035. Epub ahead of print. DOI:10.1136/gutjnl-2016-313035
   Web of Science ®Google Scholar
• Alcaraz-Quiles J , Titos E , Casulleras M , et al. Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure. Hepatology. 2017;65:202–216.
   PubMed Web of Science ®Google Scholar
• Hu F , Bi S , Yan H , et al. Associations between hepatitis B virus basal core promoter/pre-core region mutations and the risk of acute-on-chronic liver failure: a meta-analysis. Virol J. 2015;12:87.
   PubMed Web of Science ®Google Scholar
• Xu Z , Ren X , Liu Y , et al. Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol. 2011;46:391–400.
   PubMed Web of Science ®Google Scholar
• Xu H , Zhao M , Lou G , et al. New point mutations in surface and core genes of hepatitis B virus associated with acute on chronic liver failure identified by complete genomic sequencing. Plos One. 2015;10:e123139.
   PubMed Web of Science ®Google Scholar
• Chen L , Zheng CX , Lin MH , et al. Distinct quasispecies characteristics and positive selection within precore/core gene in hepatitis B virus HBV associated acute-on-chronic liver failure. J Gastroenterol Hepatol. 2013;28:1040–1046.
   PubMed Web of Science ®Google Scholar
• Yang ZT , Huang SY , Chen L , et al. Characterization of full-length genomes of hepatitis B virus quasispecies in sera of patients at different phases of infection. J Clin Microbiol. 2015;53:2203–2214.
   PubMed Web of Science ®Google Scholar
• Ren X , Xu Z , Liu Y , et al. Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat. 2010;17:887–895.
   PubMed Web of Science ®Google Scholar
• Nian X , Xu Z , Liu Y , et al. Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis. Hepatol Int. 2016;10:606–615.
   PubMed Web of Science ®Google Scholar
• Liao H , Li X , Liu Y , et al. Intergenotype recombinant analysis of full-length hepatitis B virus genomes from 516 Chinese patients with different illness categories. J Med Virol. 2017;89:139–145.
   PubMed Web of Science ®Google Scholar
• Wu W , Yan H , Zhao H , et al. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: differentiate it from No-ACLF. Liver Int. 2017 Jun 24 Epub ahead of print. DOI:10.1111/liv.13504.
   Web of Science ®Google Scholar
• Moreau R . The pathogenesis of ACLF: the inflammatory response and immune function. Semin Liver Dis. 2016;36:133–140.
   PubMed Web of Science ®Google Scholar
• Claria J , Arroyo V , Moreau R . The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray. J Immunol. 2016;197:3755–3761.
   PubMed Web of Science ®Google Scholar
• Yang Q , Shi Y , Yang Y , et al. The sterile inflammation in the exacerbation of HBV-associated liver injury. Mediators Inflamm. 2015;2015:508681.
   PubMed Web of Science ®Google Scholar
• Bernardi M , Moreau R , Angeli P , et al. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015;63:1272–1284.
   PubMed Web of Science ®Google Scholar
• Michelena J , Altamirano J , Abraldes JG , et al. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology. 2015;62:762–772.
   PubMed Web of Science ®Google Scholar
• Li H , Xia Q , Zeng B , et al. Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation. J Hepatol. 2015;63:50–59.
   PubMed Web of Science ®Google Scholar
• Du XX , Shi Y , Yang Y , et al. DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure. Liver Int. 2017. doi: 10.1111/liv.13503. [Epub ahead of print].
   Web of Science ®Google Scholar
• Shi Y , Yan H , Zhou Z , et al. The clinical course of cirrhosis patients hospitalized for acute hepatic deterioration: a prospective bicentric study. Medicine (Baltimore). 2015;94:e2031.
   PubMed Web of Science ®Google Scholar
• Rolando N , Wade J , Davalos M , et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32:734–739.
   PubMed Web of Science ®Google Scholar
• Choudhury A , Kumar M , Sharma BC, et al. Systemic inflammatory response syndrome in acute on chronic liver failure - relevance of ‘Golden Window’ - a prospective study. J Gastroenterol Hepatol. 2017;32:1989–1998.
   PubMed Web of Science ®Google Scholar
• Shah N , Dhar D , El ZMF , et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J Hepatol. 2012;56:1047–1053.
   PubMed Web of Science ®Google Scholar
• Shah N , Mohamed FE , Jover-Cobos M , et al. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Int. 2013;33:398–409.
   PubMed Web of Science ®Google Scholar
• Karagiannakis DS , Vlachogiannakos J , Anastasiadis G , et al. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci. 2013;58:3029–3036.
   PubMed Web of Science ®Google Scholar
• Panos RJ , Baker SK . Mediators, cytokines, and growth factors in liver-lung interactions. Clin Chest Med. 1996;17:151–169.
   PubMed Web of Science ®Google Scholar
• Trifan A , Chiriac S , Stanciu C . Update on adrenal insufficiency in patients with liver cirrhosis. World J Gastroenterol. 2013;19:445–456.
   PubMed Web of Science ®Google Scholar
• Antoniades CG , Berry PA , Wendon JA , et al. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol. 2008;49:845–861.
   PubMed Web of Science ®Google Scholar
• Jalan R , Gines P , Olson JC , et al. Acute-on chronic liver failure. J Hepatol. 2012;57:1336–1348.
   PubMed Web of Science ®Google Scholar
• Wasmuth HE , Kunz D , Yagmur E , et al. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol. 2005;42:195–201.
   PubMed Web of Science ®Google Scholar
• Bernsmeier C , Pop OT , Singanayagam A , et al. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology. 2015;148:603–615.
   PubMed Web of Science ®Google Scholar
• Triantafyllou E , Ot P , La P , et al. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. Gut. 2017 Apr 27. pii: gutjnl-2016-313615. Epub ahead of print. DOI:10.1136/gutjnl-2016-313615
   Web of Science ®Google Scholar
• Markwick LJ , Riva A , Ryan JM , et al. Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis. Gastroenterology. 2015;148:590–602.
   PubMed Web of Science ®Google Scholar
• Khamri W , Abeles RD , Hou TZ , et al. Increased expression of cytotoxic T-lymphocyte-associated protein 4 by T cells, induced by B7 in sera, reduces adaptive immunity in patients with acute liver failure. Gastroenterology. 2017;153:263–276.
   PubMed Web of Science ®Google Scholar
• Yang J , Yi P , Wei L , et al. Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF). J Transl Med. 2012;10:193.
   PubMed Web of Science ®Google Scholar
• Bernsmeier C , Triantafyllou E , Brenig R , et al. CD14+CD15-HLA-DR-myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. Gut. 2017 Jun 7. pii: gutjnl-2017-314184. Epub ahead of print. DOI:10.1136/gutjnl-2017-314184
   Web of Science ®Google Scholar
• Finkenstedt A , Nachbaur K , Zoller H , et al. Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list. Liver Transpl. 2013;19:879–886.
   PubMed Web of Science ®Google Scholar
• Kamath PS , Wiesner RH , Malinchoc M , et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.
   PubMed Web of Science ®Google Scholar
• Kim WR , Biggins SW , Kremers WK , et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018–1026.
   PubMed Web of Science ®Google Scholar
• Xia Q , Dai X , Zhang Y , et al. A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients. Plos One. 2013;8:e64379.
   PubMed Web of Science ®Google Scholar
• Yan H , Wu W , Yang Y , et al. A novel integrated model for end-stage liver disease model predicts short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure patients. Hepatol Res. 2015;45:405–414.
   PubMed Web of Science ®Google Scholar
• Jalan R , Saliba F , Pavesi M , et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038–1047.
   PubMed Web of Science ®Google Scholar
• Shi Y , Shu Z , Sun W , et al. Risk stratification of decompensated cirrhosis patients by Chronic Liver Failure Consortium scores: classification and regression tree analysis. Hepatol Res. 2017;47:328–337.
   PubMed Web of Science ®Google Scholar
• Sarin SK , Choudhury A . Acute-on-chronic liver failure. Curr Gastroenterol Rep. 2016;18:61.
   PubMedGoogle Scholar
• Cao Z , Li F , Xiang X , et al. Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure. Sci Rep. 2015;5:14240.
   PubMed Web of Science ®Google Scholar
• Wei H , Zhang J , Li H , et al. GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections. Diagn Microbiol Infect Dis. 2014;79:19–24.
   PubMed Web of Science ®Google Scholar
• Chan AC , Fan ST . Criteria for liver transplantation in ACLF and outcome. Hepatol Int. 2015;9:355–359.
   PubMed Web of Science ®Google Scholar
• Artru F , Louvet A , Ruiz I , et al. Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3. J Hepatol. 2017;67:708–715.
   PubMed Web of Science ®Google Scholar
• Duan BW , Lu SC , Wang ML , et al. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases. J Surg Res. 2013;183:936–943.
   PubMed Web of Science ®Google Scholar
• Gane EJ , Angus PW , Strasser S , et al. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology. 2007;132:931–937.
   PubMed Web of Science ®Google Scholar
• Garg H , Sarin SK , Kumar M , et al. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011;53:774–780.
   PubMed Web of Science ®Google Scholar
• Yu S , Jianqin H , Wei W , et al. The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis. Ann Hepatol. 2013;12:364–372.
   PubMed Web of Science ®Google Scholar
• Cui YL , Yan F , Wang YB , et al. Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Dig Dis Sci. 2010;55:2373–2380.
   PubMed Web of Science ®Google Scholar
• Huang KW , Tam KW , Luo JC , et al. Efficacy and safety of lamivudine versus entecavir for treating chronic hepatitis B virus-related acute exacerbation and acute-on-chronic liver failure: a systematic review and meta-analysis. J Clin Gastroenterol. 2017;51:539–547.
   PubMed Web of Science ®Google Scholar
• Li H , Chen HS , Nyberg SL . Extracorporeal liver support and liver transplant for patients with acute-on-chronic liver failure. Semin Liver Dis. 2016;36:153–160.
   PubMed Web of Science ®Google Scholar
• Chen JJ , Huang JR , Yang Q , et al. Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China. Hepatobiliary Pancreat Dis Int. 2016;15:275–281.
   PubMed Web of Science ®Google Scholar
• Banares R , Nevens F , Larsen FS , et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57:1153–1162.
   PubMed Web of Science ®Google Scholar
• Kribben A , Gerken G , Haag S , et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:782–789.
   PubMed Web of Science ®Google Scholar
• Larsen FS , Schmidt LE , Bernsmeier C , et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64:69–78.
   PubMed Web of Science ®Google Scholar
• Qin G , Shao JG , Wang B , et al. Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience. Medicine (Baltimore). 2014;93:e338.
   PubMed Web of Science ®Google Scholar
• Sussman NL , Kelly JH . Artificial liver. Clin Gastroenterol Hepatol. 2014;12:1439–1442.
   PubMed Web of Science ®Google Scholar
• Demetriou AA , Brown RJ , Busuttil RW , et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239(660–667):667–670.
   Google Scholar
• Fujiwara K , Yasui S , Yonemitsu Y , et al. Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B. J Gastroenterol. 2008;43:711–719.
   PubMed Web of Science ®Google Scholar
• Zhao J , Zhang JY , Yu HW , et al. Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy. Cell Mol Immunol. 2012;9:417–422.
   PubMed Web of Science ®Google Scholar
• Chen JF , Wang KW , Zhang SQ , et al. Dexamethasone in outcome of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroenterol Hepatol. 2014;29:800–806.
   PubMedGoogle Scholar
• Fujiwara K , Yasui S , Okitsu K , et al. The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B. J Gastroenterol. 2010;45:1255–1262.
   PubMed Web of Science ®Google Scholar
• Garg V , Garg H , Khan A , et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:505–512.
   PubMed Web of Science ®Google Scholar
• Khanam A , Trehanpati N , Garg V , et al. Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on-chronic liver failure. Liver Int. 2014;34:505–513.
   PubMed Web of Science ®Google Scholar
• Rolando N , Clapperton M , Wade J , et al. Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure. Eur J Gastroenterol Hepatol. 2000;12:1135–1140.
   PubMed Web of Science ®Google Scholar
• Chavez-Tapia NC , Mendiola-Pastrana I , Ornelas-Arroyo VJ , et al. Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis. Ann Hepatol. 2015;14:631–641.
   PubMed Web of Science ®Google Scholar
• Duan XZ , Liu FF , Tong JJ , et al. Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol. 2013;19:1104–1110.
   PubMed Web of Science ®Google Scholar
• Tsolaki E , Yannaki E . Stem cell-based regenerative opportunities for the liver: state of the art and beyond. World J Gastroenterol. 2015;21:12334–12350.
   PubMed Web of Science ®Google Scholar
• Shi D , Zhang J , Zhou Q , et al. Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs. Gut. 2017;66:955–964.
   PubMed Web of Science ®Google Scholar
• Shi M , Zhang Z , Xu R , et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1:725–731.
   PubMed Web of Science ®Google Scholar
• Lin BL , Chen JF , Qiu WH , et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial. Hepatology. 2017;66:209–219.
   PubMed Web of Science ®Google Scholar
• Mookerjee RP , Pavesi M , Thomsen KL , et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol. 2016;64:574–582.
   PubMed Web of Science ®Google Scholar